• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在英国引入基于核糖体分型的全国监测计划后,艰难梭菌感染的流行病学发生变化。

Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England.

机构信息

Department of Microbiology, Old Medical School, Leeds General Infirmary, Thoresby Place, Leeds LS1 3EX, United Kingdom.

出版信息

Clin Infect Dis. 2012 Oct;55(8):1056-63. doi: 10.1093/cid/cis614. Epub 2012 Jul 11.

DOI:10.1093/cid/cis614
PMID:22784871
Abstract

BACKGROUND

Marked increases in Clostridium difficile infection (CDI) incidence, driven by epidemic strain spread, is a global phenomenon.

METHODS

The Clostridium difficile Ribotyping Network (CDRN) was established in 2007 as part of enhanced CDI surveillance in England, to facilitate the recognition and control of epidemic strains. We report on changes in CDI epidemiology in England in the first 3 years of CDRN.

RESULTS

CDRN received 12,603 fecal specimens, comprising significantly (P < .05) increasing numbers and proportions of national CDI cases in 2007-2008 (n = 2109, 3.8%), 2008-2009 (n = 4774, 13.2%), and 2009-2010 (n = 5720, 22.3%). The C. difficile recovery rate was 90%, yielding 11,294 isolates for ribotyping. Rates of 9 of the 10 most common ribotypes changed significantly (P < .05) during 2007-2010. Clostridium difficile ribotype 027 predominated, but decreased markedly from 55% to 36% and 21% in 2007-2008, 2008-2009, and 2009-2010, respectively. The largest regional variations in prevalence occurred for ribotypes 027, 002, 015, and 078. Cephalosporin and fluoroquinolone use in CDI cases was reported significantly (P < .05) less frequently during 2007-2010. Mortality data were subject to potential reporting bias, but there was a significant decrease in CDI-associated deaths during 2007-2010, which may have been due to multiple factors, including reduced prevalence of ribotype 027.

CONCLUSIONS

Access to C. difficile ribotyping was associated with significant changes in the prevalence of epidemic strains, especially ribotype 027. These changes coincided with markedly reduced CDI incidence and related mortality in England. CDI control programs should include prospective access to C. difficile typing and analysis of risk factors for CDI and outcomes.

摘要

背景

产毒艰难梭菌(CDI)感染率的显著增加是由流行株传播引起的,这是一种全球现象。

方法

艰难梭菌核糖体分型网络(CDRN)于 2007 年成立,作为英国增强 CDI 监测的一部分,以促进对流行株的识别和控制。我们报告了 CDRN 成立的头 3 年英格兰 CDI 流行病学的变化。

结果

CDRN 收到了 12603 份粪便标本,2007-2008 年(n = 2109,3.8%)、2008-2009 年(n = 4774,13.2%)和 2009-2010 年(n = 5720,22.3%)国家 CDI 病例的数量和比例均显著增加(P <.05)。艰难梭菌的回收率为 90%,共进行了 11294 株的核糖体分型。2007-2010 年间,10 种最常见核糖体型中的 9 种的发生率均发生了显著变化(P <.05)。艰难梭菌核糖体型 027 占主导地位,但在 2007-2008 年、2008-2009 年和 2009-2010 年分别显著下降了 55%、36%和 21%。在流行率方面,核糖体型 027、002、015 和 078 存在最大的地区差异。2007-2010 年,CDI 病例中头孢菌素和氟喹诺酮类药物的使用报告显著减少(P <.05)。CDI 相关死亡率的数据可能存在报告偏倚,但 2007-2010 年间 CDI 相关死亡人数显著下降,这可能是由于多种因素造成的,包括核糖体型 027 的流行率降低。

结论

艰难梭菌核糖体分型的获得与流行株流行率的显著变化有关,特别是核糖体型 027。这些变化与英格兰 CDI 发病率和死亡率的显著下降同时发生。CDI 控制计划应包括对艰难梭菌定型的前瞻性评估以及对 CDI 风险因素和结局的分析。

相似文献

1
Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England.在英国引入基于核糖体分型的全国监测计划后,艰难梭菌感染的流行病学发生变化。
Clin Infect Dis. 2012 Oct;55(8):1056-63. doi: 10.1093/cid/cis614. Epub 2012 Jul 11.
2
Enhanced surveillance of Clostridium difficile infection occurring outside hospital, England, 2011 to 2013.强化监测英格兰地区 2011 至 2013 年发生在医院外的艰难梭菌感染。
Euro Surveill. 2016 Jul 21;21(29). doi: 10.2807/1560-7917.ES.2016.21.29.30295.
3
Infection due to C. difficile ribotype 078: first report of cases in the Republic of Ireland.艰难梭菌 078 型导致的感染:爱尔兰共和国的首例报告。
J Hosp Infect. 2010 Aug;75(4):287-91. doi: 10.1016/j.jhin.2010.03.025. Epub 2010 Jun 17.
4
Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013.艰难梭菌 PCR 核糖型在欧洲的多样性:来自于 2012 年和 2013 年欧洲、多中心、前瞻性、半年一次、对住院腹泻患者艰难梭菌感染的点患病率研究(EUCLID)的结果。
Euro Surveill. 2016 Jul 21;21(29). doi: 10.2807/1560-7917.ES.2016.21.29.30294.
5
Reduction in Clostridium difficile infections in Finland, 2008-2010.2008-2010 年芬兰艰难梭菌感染减少。
J Hosp Infect. 2013 Feb;83(2):127-31. doi: 10.1016/j.jhin.2012.09.021. Epub 2012 Nov 30.
6
Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013.基于医院的艰难梭菌感染监测显示,2011 年至 2013 年期间,波兰不同地区的 PCR 核糖型 027 和 176 比例较高。
Euro Surveill. 2015;20(38). doi: 10.2807/1560-7917.ES.2015.20.38.30025.
7
Increasing prevalence of the epidemic ribotype 106 in healthcare facility-associated and community-associated Clostridioides difficile infection.流行株 106 在医疗机构相关性和社区相关性艰难梭菌感染中的流行率不断增加。
Anaerobe. 2019 Feb;55:124-129. doi: 10.1016/j.anaerobe.2018.12.002. Epub 2018 Dec 11.
8
Analysis of prevalence, risk factors and molecular epidemiology of Clostridium difficile infection in Kuwait over a 3-year period.在过去的 3 年中,科威特艰难梭菌感染的流行率、危险因素和分子流行病学分析。
Anaerobe. 2010 Dec;16(6):560-5. doi: 10.1016/j.anaerobe.2010.09.003. Epub 2010 Sep 29.
9
Detection of cross-infection associated to a Brazilian PCR-ribotype of Clostridium difficile in a university hospital in Rio de Janeiro, Brazil.巴西里约热内卢一所大学医院中与一种巴西 PCR 型艰难梭菌相关的交叉感染检测。
Antonie Van Leeuwenhoek. 2011 Feb;99(2):249-55. doi: 10.1007/s10482-010-9483-8. Epub 2010 Jul 11.
10
Clinical features and characteristics of Clostridium difficile PCR-ribotype 176 infection: results from a 1-year university hospital internal ward study.艰难梭菌PCR核糖体分型176感染的临床特征:一项为期1年的大学医院内科病房研究结果
Ann Clin Microbiol Antimicrob. 2015 Dec 23;14:55. doi: 10.1186/s12941-015-0114-0.

引用本文的文献

1
Epidemiology and genetic characteristics of isolates in Northwest China.中国西北地区分离株的流行病学和遗传特征
PeerJ. 2025 Aug 15;13:e19877. doi: 10.7717/peerj.19877. eCollection 2025.
2
Whole genome sequence analysis reveals limited diversity among Clostridioides difficile ribotype 027 and 078 isolates collected in 22 hospitals in Berlin and Brandenburg, Germany.全基因组序列分析显示,在德国柏林和勃兰登堡的22家医院收集的艰难梭菌核糖体分型027和078分离株之间存在有限的多样性。
Antimicrob Resist Infect Control. 2025 May 28;14(1):56. doi: 10.1186/s13756-025-01565-y.
3
Molecular Epidemiology of Infections in Patients Hospitalized in 2017-2019 at the Central Teaching Hospital of Medical University of Lodz, Central Poland.
2017 - 2019年波兰中部罗兹医科大学中央教学医院住院患者感染的分子流行病学
Antibiotics (Basel). 2025 Feb 21;14(3):219. doi: 10.3390/antibiotics14030219.
4
Clostridioides difficile infections caused by hypervirulent strains: a single-centre real-life study.由高毒力菌株引起的艰难梭菌感染:一项单中心真实世界研究。
Eur J Clin Microbiol Infect Dis. 2025 Jan;44(1):99-107. doi: 10.1007/s10096-024-04982-w. Epub 2024 Nov 11.
5
Reduced Vancomycin Susceptibility in Is Associated With Specific Ribotypes.万古霉素敏感性降低与特定核糖体分型相关。
Open Forum Infect Dis. 2024 Oct 10;11(11):ofae588. doi: 10.1093/ofid/ofae588. eCollection 2024 Nov.
6
Genetic determinants of resistance to antimicrobial therapeutics are rare in publicly available Clostridioides difficile genome sequences.在公开的艰难梭菌基因组序列中,对抗菌治疗有抗性的遗传决定因素很少。
J Antimicrob Chemother. 2024 Jun 3;79(6):1320-1328. doi: 10.1093/jac/dkae101.
7
The Need for European Surveillance of CDI.欧洲需要对 CDI 进行监测。
Adv Exp Med Biol. 2024;1435:13-31. doi: 10.1007/978-3-031-42108-2_2.
8
Prevalence and Risk Factors of Clostridium difficile Infection Among Patients Hospitalized for a Flare of Inflammatory Bowel Disease in King Abdulaziz University Hospital.阿卜杜勒阿齐兹国王大学医院炎症性肠病发作住院患者艰难梭菌感染的患病率及危险因素
Cureus. 2023 Nov 7;15(11):e48451. doi: 10.7759/cureus.48451. eCollection 2023 Nov.
9
Prevalence of diagnostically-discrepant clinical specimens: insights from longitudinal surveillance.诊断结果存在差异的临床标本的流行情况:纵向监测的见解
Front Med (Lausanne). 2023 Oct 18;10:1238159. doi: 10.3389/fmed.2023.1238159. eCollection 2023.
10
Insights into the Evolving Epidemiology of Infection and Treatment: A Global Perspective.《感染与治疗的演变流行病学洞察:全球视角》
Antibiotics (Basel). 2023 Jul 1;12(7):1141. doi: 10.3390/antibiotics12071141.